These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14694766)

  • 21. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Creutzig A; Creutzig H; Alexander K
    Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebral oxygenation during prostaglandin E1 induced hypotension.
    Kadoi Y; Saito S; Kunimoto F; Morita T; Goto F; Kawahara F; Fujita N
    Can J Anaesth; 1998 Sep; 45(9):860-4. PubMed ID: 9818109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW
    Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravenous iloprost and alprostadil (PGE1) on peripheral resistance during femoro-distal reconstructions.
    Krueger U; Scholz H; Heise M; Adeberg P; Petzold M; Zanow J; Karrenberg R
    Int Angiol; 2000 Dec; 19(4):358-65. PubMed ID: 11305737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
    Horch R; Krönung G
    Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
    [No Abstract]   [Full Text] [Related]  

  • 30. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.
    Makino H; Aoki M; Hashiya N; Yamasaki K; Hiraoka K; Shimizu H; Azuma J; Kurinami H; Ogihara T; Morishita R
    Hypertens Res; 2004 Feb; 27(2):85-91. PubMed ID: 15005271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
    Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H
    Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
    Goto J; Araki H; Otomo S; Aihara H
    Drugs Exp Clin Res; 1986; 12(11):917-21. PubMed ID: 3816509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A; Bruch HP; Hörl M; Düsel W
    Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in pulmonary arterial diameter under prostaglandin E1 therapy in infants with cyanotic congenital heart disease.
    Ito T; Harada K; Tamura M; Takada G
    Pediatr Cardiol; 1998; 19(5):404-7. PubMed ID: 9703565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralization of prostaglandin E1 intravenous solution reduces infusion phlebitis.
    Fujita M; Hatori N; Shimizu M; Yoshizu H; Segawa D; Kimura T; Iizuka Y; Tanaka S
    Angiology; 2000 Sep; 51(9):719-23. PubMed ID: 10999612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
    Gianetti J; De Caterina M; De Cristofaro T; Ungaro B; Guercio RD; De Caterina R
    Am Heart J; 2001 Oct; 142(4):733-9. PubMed ID: 11579367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
    Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
    Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease.
    Trifiletti A; Scamardi R; Pizzoleo MA; Sottilotta G; Soraci S; Attinà A; Bagnato L; Barbera N
    Panminerva Med; 1999 Mar; 41(1):15-7. PubMed ID: 10230250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.
    Creutzig A; Lehmacher W; Elze M
    Vasa; 2004 Aug; 33(3):137-44. PubMed ID: 15461065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.
    Hirai M; Nakayama R
    Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.